Charlie's Holdings, Inc.
0.2700-0.01 (-2.03%)
Oct 29, 4:00:00 PM EDT · OTC Markets OTCQB · CHUC · USD
Key Stats
Market Cap
70.86MP/E (TTM)
-Basic EPS (TTM)
0.00Dividend Yield
0%Recent Filings
10-Q
Q2 FY2025 results
Charlie's Holdings swung to profitability in Q2 FY2025 ended June 30, 2025, posting net income of $4.961M on $2.544M revenue, up 24.5% y/y from $2.043M, while YTD revenue dipped 4.8% y/y to $4.850M but net income hit $3.744M versus a $2.012M loss last year. Operating loss widened slightly to $877K from $736K y/y amid higher COGS at 73.9% of revenue, yet a $6.5M gain from selling PMTA assets to R.J. Reynolds Vapor Company in April-May 2025 for cash turned the tide, alongside $99K debt extinguishment gain; taxes took $426K. Cash climbed to $1.453M with $2.211M working capital, total debt at $825K maturing mostly in 2026, and free cash flow not disclosed in the 10-Q. The asset sale closed for $6.5M cash plus up to $4.2M contingent, recognizing no goodwill. Diluted EPS of $0.02 reconciles to 281.98M shares with no anti-dilution flagged. Regulatory hurdles loom large.
8-K
Asset sale amendment closed
Charlie's Holdings closed an asset sale amendment on August 8, 2025, to R.J. Reynolds Vapor Company, offloading one more PMTA-covered synthetic product and related assets for $1.0 million at closing—now totaling sixteen items sold. This bolsters cash flow while streamlining the portfolio. Directors were elected at the August 7 annual meeting. Auditors ratified.
10-Q
Q1 FY2025 results
Charlie's Holdings saw product revenue drop 24.4% y/y to $2.3M in Q1 FY2025 ended March 31, 2025, mainly from softer nicotine vapor sales, yet operating loss narrowed 12.2% to $826K thanks to 21.5% lower expenses and cost controls like headcount cuts. Gross margin slipped to 22.9% from 30.9% on fixed cost pressures, while net loss widened 16.5% to $1.2M, driven by $149K debt extinguishment and higher interest, exceeding operating loss by over 20% due to those items. Cash dipped to $112K with $409K used in operations, but post-quarter asset sales to R.J. Reynolds for $6.5M cleared key debts and boosted liquidity. No non-GAAP metrics disclosed in the 10-Q. FDA regulatory hurdles loom large.
8-K
Sells more PACHA assets
Charlie's Holdings amended its asset purchase agreement with R. J. Reynolds Vapor Company on May 29, 2025, selling three additional PACHA synthetic products and related assets covered by a 2022 PMTA for $1.5 million at closing. This brings the total products sold to fifteen, bolstering the company's cash position from divesting non-core vaping assets. Deal closed swiftly. No integration details or forward guidance disclosed.
10-K
FY2024 results
Charlie's Holdings posted FY2024 revenue of $8.5 million, down 47.7% year-over-year from $16.3 million in 2023, as the company pivoted to non-nicotine SBX disposables launched in Q4, offsetting regulatory pressures on legacy nicotine products amid a 48% drop in nicotine sales. While annual gross margins compressed to 66.0% from 62.8% due to lower volumes, Q4 saw initial SBX test-marketing gains in convenience chains, with focus groups favoring its flavors over Juul by 94%, signaling potential momentum despite a $3.5 million operating loss. Liquidity tightened to a $1.9 million working capital deficit, eased by $2.2 million in equity raises and note restructurings, yet cash burn hit $1.6 million. No 2025 guidance disclosed, but PMTA enhancements cost $1.2 million in Q4. Regulatory uncertainty over FDA jurisdiction looms large.
BTI
British American Tobacco Indus
51.72-0.74
CWBHF
Charlotte's Web Holdings Inc.
0.16-0.00
HCMC
Healthier Choices Management Co
0.00+0.00
KAVL
Kaival Brands Innovations Group
0.57-0.01
MO
Altria Group, Inc.
61.97-1.31
PM
Philip Morris International Inc
146.77-3.04
PYYX
Pyxus International, Inc.
2.25+0.00
RLX
RLX Technology Inc.
2.39-0.03
TOBAF
TAAT Global Alternatives Inc.
0.09+0.02
TPB
Turning Point Brands, Inc.
88.16-0.69